RPS10P19: A Promising Drug Target / Biomarker (G100271350)

Target Name: RPS10P19

NCBI ID: G100271350

RPS10P19

Other Name(s): Ribosomal protein S10 pseudogene 19 | ribosomal protein S10 pseudogene 19 | RPS10_7_1142

RPS10P19: A Promising Drug Target / Biomarker

The protein RPS10P19 is a key regulator of the poly(ADP-ribose) polymerase (PARP) complex, which is involved in the repair of DNA damage. PARP is a protein that plays a crucial role in maintaining cellular homeostasis, as it helps regulate the levels ofADP-ribose in the cell. RPS10P19 is a key component of the PARP complex, and its dysfunction has been implicated in a number of diseases, including cancer. As a result, RPS10P19 has become a focus of interest for researchers studying the role of this protein in human disease.

Drug Targeting

One of the main goals of drug development is to identify compounds that can modulate the activity of RPS10P19 and improve its function. This is an important goal because modulating the activity of RPS10P19 has the potential to treat a wide range of diseases. For example, RPS10P19 is involved in the regulation of DNA repair, which is a critical process that helps prevent the development of cancer. Therefore, compounds that can modulate RPS10P19 activity could be useful for treating cancer.

An Overview of RPS10P19

RPS10P19 is a protein that is expressed in most tissues of the body. It is a member of the superfamily of proteins known as the Rho family, and it is involved in a number of cellular processes. RPS10P19 is a key regulator of the PARP complex, which is a protein that plays a crucial role in maintaining cellular homeostasis. The PARP complex is composed of a number of different proteins, including RPS10P19, which is responsible for regulating the activity of the other proteins in the complex.

The RPS10P19 protein is involved in the regulation of several different processes in the cell. It is involved in the regulation of cell adhesion, which is the process by which cells stick together and form tissues. RPS10P19 is also involved in the regulation of cell signaling, which is the process by which cells communicate with each other and with their surroundings.

Disease and RPS10P19

RPS10P19 dysfunction has been implicated in a number of diseases, including cancer. In cancer, RPS10P19 is often overexpressed, which means that it is produced at higher levels than it should be. This increase in RPS10P19 production can lead to a number of different consequences, including the development of cancer cells.

One of the main consequences of RPS10P19 dysfunction is the development of DNA repair deficiencies. DNA repair is a critical process that helps prevent the development of cancer cells. If RPS10P19 is unable to function properly, it can cause DNA repair deficiencies, which can lead to the development of cancer.

Another consequence of RPS10P19 dysfunction is the development of cellular stress. Cellular stress is a natural response of cells to certain stimuli, such as damage to their DNA. However, if RPS10P19 is unable to function properly, it can cause cellular stress, which can lead to the development of a wide range of diseases.

The Potential for Drug Development

Despite the many functions of RPS10P19, it is still an area of active research. There is a need for new drugs that can modulate the activity of RPS10P19 and improve its function. This is an important goal because modulating the activity of RPS10P19 has the potential to treat a wide range of diseases.

One approach to drug development that is being explored is the use of small molecules as

Protein Name: Ribosomal Protein S10 Pseudogene 19

The "RPS10P19 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RPS10P19 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets